A U.S. securities‑litigation firm announced an investigation into Rezolve AI (NASDAQ: RZLV) following short‑seller and forensic reports alleging fabricated growth and questionable acquisitions. The notice signals potential shareholder litigation and heightened regulatory scrutiny into alleged misstatements to investors.

A U.S. securities‑litigation firm disclosed an investigation into Rezolve AI plc (NASDAQ: RZLV) after public short‑seller and forensic reports raised allegations that the company may have misrepresented growth metrics and engaged in dubious acquisition practices. The inquiry centers on whether Rezolve AI made materially misleading statements or omitted critical information that investors would consider material to investment decisions. The announcement typically precedes shareholder suits and may attract scrutiny from regulators tasked with policing securities disclosures and market manipulation. Observers note this fits a recurring pattern in the AI and technology sectors, where rapid valuations and complex deal structures have prompted enhanced forensic review and legal action when inconsistencies arise. Potential outcomes range from civil litigation and settlements to regulatory enforcement, depending on the strength of the evidence and the company’s disclosures. Investors and market participants are watching for additional filings, auditor statements and any formal regulatory probes that could clarify responsibilities and potential remediation steps.